Immunology


Single-Cell Proteomics of Localized Prostate Cancer Defines Disease Heterogeneity
Prostate cancer affects about 12.6% of men over the course of their lives, and while most individuals with localized disease can be cured, disease does recur in a small number of patients. The treatment of localized prostate cancer is based on clinicopathological information including Gleason score, prostate-specific antigen (PSA) levels, stage, and patient age. More...26 Apr 2022

New BD Assay Speeds Discovery in Autoimmune Disorders, Immuno-Oncology, and Infectious Diseases
Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) has launched the BD Rhapsody TCR/BCR Multiomic Assay, an innovative set of reagents that enables researchers to more easily and comprehensively analyze important cells in the immune system, providing a tool to advance research in autoimmune disorders, immuno-oncology and infectious diseases. More...22 Apr 2022

Tumor Suppressor Adenomatous Polyposis Coli Regulates T Lymphocyte Migration
Familial adenomatous polyposis (FAP) is an autosomal dominant inherited disease that often results from germline mutations in the adenomatous polyposis coli (APC) gene, a tumor suppressor and polarity regulator. APC protein regulates the Wnt/β-catenin signaling pathway as a component of the β-catenin destruction complex. More...20 Apr 2022

Neurofilament Light Biomarker Linked With Parkinson's Disease
Parkinson's disease is caused by a loss of nerve cells in part of the brain called the substantia nigra. This leads to a reduction in a chemical called dopamine in the brain. Blood biomarkers may allow earlier identification of Parkinson’s disease (PD), Parkinsonism, and poor PD-related outcomes, such as physical functioning. More...19 Apr 2022

Lateral Flow Immunoassay Developed for Detecting Yersinia Pestis
Yersinia pestis is the causative agent of plague, a zoonosis associated with small mammals. Plague is a severe disease, especially in the pneumonic and septicemic forms, where fatality rates approach 100% if left untreated. More...07 Apr 2022

Serum Antinuclear Antibody Correlated in Hispanic Pediatric Patients With NFLD
Non-alcoholic fatty liver disease (NAFLD), also known as metabolic (dysfunction) associated fatty liver disease (MAFLD), is excessive fat build-up in the liver without another clear cause such as alcohol use. Obesity and type 2 diabetes are strong risk factors for NAFLD. More...06 Apr 2022
In Other News
Pediatric Antiphospholipid Syndrome Diagnosis Methods Reassessed
Double-Antigen Sandwich ELISA Detects Antibodies to Trypanosoma cruzi
Flow Cytometric Immunophenotyping Assessed for Classic Hodgkin Lymphoma
Biomarker Panel for Risk of Early Respiratory Failure Following Hematopoietic Cell Transplantation
Serum Extracellular Vesicle Arginase 1 Measured In T2DM
Enzyme Immunoassays Developed for Serodiagnosis of Human Leptospirosis
Diagnostic Biomarker Predicts Risk of Opisthorchiasis Cholangiocarcinoma
Different Assay Evaluated for Thyroglobulin and Thyroglobulin Antibodies
Immunohistochemistry Evaluated for Tissue-Invasive Cytomegalovirus in Gastrointestinal Mucosal Biopsies
Low Levels of IL-39 Associated With Autoimmune Thyroid Disease
Immunoassay Detects Pancreatic Cancer in People at High Risk
Chromosomally Normal Miscarriage Is Associated With Vaginal Dysbiosis
Novel Immune-Profiling Method Reports Specific Immune Cell Types Using Only DNA from Blood
Elevated Interleukin-12/23p40 Indicates Dysfunctional Heart Rate Variability in T2D
High-Speed Fluorescence Image-Enabled Cell Sorting Tested
ABO Blood Group Related to Specific Immune Response to Anti-SARS-CoV-2
Melanoma Test Offers Reassurance of Low Risk of Cancer Spread
Biomarkers Linked to Autism Risk Identified
Immune System Can Detect Disease During Pregnancy
Natural Killer Cell-Associated Markers Investigated in Gastric Cancer
Regulatory and Other Rheumatoid Factors Analyzed in RA Patients
Association Between Helicobacter pylori With Nonalcoholic Fatty Liver Disease Assessed
Biomarker FR+CTC Explored for Breast Cancer Diagnosis
The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.